Jan Ross began the new treatment for myeloma after finding previous medication had "really challenging" side effects
Jan Ross, 57, from Liverpool, entered a trial at Manchester's The Christie in November after finding previous treatments for myeloma had "really challenging" side effects.Haematologist Dr Emma Searle said the results were "incredibly impressive". However, she said since November, she had not had any and has recently been on her first holiday since she first became ill.
"We know the [standard] tablet alone doesn't work well in her any more, but in this trial, it seems to help the immunotherapy work even better," she said."She has tolerated the drug well with minimal side effects, feels well and can enjoy life."
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: